ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HIK Hikma Pharmaceuticals Plc

1,913.00
59.00 (3.18%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  59.00 3.18% 1,913.00 1,916.00 1,918.00 1,920.00 1,861.00 1,861.00 522,491 16:35:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8685 22.08 4.24B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,854p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,711.00p to 2,222.00p.

Hikma Pharmaceuticals currently has 221,081,676 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.24 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 22.08.

Hikma Pharmaceuticals Share Discussion Threads

Showing 876 to 900 of 1875 messages
Chat Pages: Latest  39  38  37  36  35  34  33  32  31  30  29  28  Older
DateSubjectAuthorDiscuss
13/11/2017
16:04
Keep waiting for this to trend sideways before considering a purchase, but it keeps falling. 900p not all that far away.
its the oxman
09/11/2017
20:55
Surprised to see that they still have a major disagreement with FDA. It will be great if they can resolve the issue in Q1 2018 .
karateboy
09/11/2017
14:05
Could have been a shorters last hurrah before the big boys pile back in.

The FDA problems started this slide. If it gets sorted out the upside should be excellent.

Time will tell as always....

bantam175
09/11/2017
09:24
awful stuff, I do not understand why institutions were buying so heavily recently - they are losing millions - they haven't got a clue. maybe a bounce in coming days?
chc15
09/11/2017
09:10
Buy note out from Numis this morning £13
nortic 007
09/11/2017
08:42
Hard to believe there was a broker forecast of £35 earlier this year.
bantam175
09/11/2017
08:36
PER still looks generous imv, however there may be more sector
consolidation at some point imv.

essentialinvestor
09/11/2017
08:15
Bant - agree.

Hikma Pharmaceuticals has revised its full year expectations for its generics business but continues to expect full year revenue to be around $2.0bn in constant currency.

The group said its injectables and branded businesses were delivering a good performance but like many of its competitors, it was experiencing challenging conditions in the US generics market.

broadwood
09/11/2017
08:08
This is nuts. They continue to expect full year revenue to be around $2.0 billion in constant currency in 2017 and get a drop like this?
bantam175
09/11/2017
07:52
Panmure calling it down 5% .... see what the mkt thinks......

One to keep on the watch list if it gets really ugly but nothing in there today which screams falls overdone etc....IMO

soundbuy
09/11/2017
07:42
I sincerely hope so - it was £22 and now almost £10. One hell if a drop.
Suet

suetballs
09/11/2017
07:38
Is this all in the price?
broadwood
09/11/2017
07:33
Not fast growing anymore!
Significant headwinds.
Doh!
Suet

suetballs
08/11/2017
18:00
Trading update tomorrow - hopeful for some encouraging news.
Suet

suetballs
08/11/2017
15:50
The pain continues.
Suet

suetballs
07/11/2017
16:19
What caused the fall?
celeritas
07/11/2017
15:52
If it break £10 then I see the next stop around 7.50 That's where i am targeting my buy in Gla
specul82
07/11/2017
15:30
Electronic order book surely.

You can buy GILD or Shire on around 11-12x- depending on which figures you use, with the advantages of product patent protection.

Perhaps Hikma is worth more to someone else(would expect sector consolidation)
or to one of the major shareholders, otherwise it does not look particularly
cheap to me. Just my view only, may be wrong.

essentialinvestor
07/11/2017
15:23
who knows, getting beat up again, the MM's playing games. Gotta be a takeover target too now.
chc15
07/11/2017
14:43
I suspect it won't gain 50% in two months. I do suspect that it will reach a price at which it is oversold, 9 quid is getting closer...
andyj
07/11/2017
07:31
This will be back up in the £15 margin by January I suspect. Good luck with your £9
gozzy90
07/11/2017
00:06
I am hanging on for 9 quid.
andyj
06/11/2017
19:35
As I have said before, this is a value buy now, and there has been a big buyer in the background. I'm staying put, and adding if goes lower.
chc15
06/11/2017
16:02
New PPI products approved by FDA and raising of prices of its US products should help drive growth.
justiceforthemany
06/11/2017
16:01
Drop from 2300p to 1080p seems unjustified IMO
justiceforthemany
Chat Pages: Latest  39  38  37  36  35  34  33  32  31  30  29  28  Older

Your Recent History

Delayed Upgrade Clock